C-Papers


论文题名
血清抗苗勒管激素检测40岁以上不孕患者IVF中临床意义的探讨
Title
Clinical significance of serum anti-Müllerian hormone detection of IVF in infertile patients over 40 years of age
作者
张玲;邸玥莹;梅俊;蓝惠华;高鹏;王厚照
Institution
厦门大学附属成功医院/解放军第174医院中心实验室
期刊名称
中国优生与遗传杂志
CN
11-3743/R
ISSN
1006-9534
出版日期
2016-11-25
Volume
v.24
Issue
11
YM
92+109-110
GJZ
高龄不孕;抗苗勒氏管激素;体外受精;妊娠
Keywords
Aged infertility;Anti-Müllerian hormone;Fertilization in vitro;Pregnancy rate
LWZY
目的探讨抗苗勒氏管激素(AMH)水平对年龄超过40岁的患者行体外受精-胚胎移植、卵胞浆内单精子注射(IVF/ICSI-ET)周期妊娠结局的预测意义。方法我们回顾性分析了我院生殖中心就诊的188名年龄在40岁到44岁接受IVF/ICSI新鲜胚胎移植周期不孕患者的医疗记录。患者随机分为A组,与AMH水平<1ng/ml(n=97),B组与AMH水平≥1ng/ml(n=91)。我们比较了两组的临床妊娠率(CPR),并进行了逻辑回归分析。结果 A组的临床妊娠率明显低于B组(24.2%比7.2%,P﹤0.001),多因素Logistic回归分析,AMH水平是对临床妊娠率显著影响的唯一因素(优势比,1.510;95%置信区间,1.172-1.947)。结论我们的研究表明,AMH水平预测年龄超过40岁不孕患者临床妊娠结局。
Abstract
Objective:To determine the predictive value of anti-Müllerian hormone(AMH)levels for pregnancy outcomes in patients over 40 years of age who underwent in vitro fertilization or intracytoplasmic sperm injection-embryo transfer(IVF/ICSI-ET)cycles. Methods:We retrospectively analyzed the medical records of 188 women aged 40 to 44 years who underwent IVF/ICSI-fresh ET cycles due to unexplained infertility in the reproductive center of our hospital. Patients were divided into group A,with AMH levels <1.0 ng/ml(n=97),and group B,with AMH levels ≥1.0 ng/ml(n=91). We compared the clinical pregnancy rate(CPR)in the two groups and performed logistic regression analysis to identify factors that had a significant effect on the CPR. Results:The CPR was significantly lower in group A than group B(7.2% vs. 24.2%, P﹤0.001). In multivariate logistic regression analysis,AMH levels were the only factor that had a significant impact on the CPR(odds ratio,1.510;95% confidence interval,1.172-1.947). Conclusion:Our study showed that AMH levels were predictive of clinical pregnancy in infertility patients over 40 years of age.
Ref
[1]Weenen C,Laven JS,Von Bergh AR,et al.Anti-Mulleria n hormone expression pattern in the human ovary:potential implications for initial and cyclic follicle recruitment[J].Mol Hum Reprod,2004,10:77-83. [2]Fanchin R,Mendez Lozano DH,Louafi N,et al.Dynamics of serum anti-Mullerian hormone levels during the luteal phase of controlled ovarian hyperstimulation[J].Hum Reprod,2005,20:747-751. [3]Patrelli TS,Gizzo S,Sianesi N,et al.Anti-Mullerian hormone serum values and ovarian reserve:can it predict a decrease in fertility after ovarian stimulation by ART cycles?[J].PLo S One,2012,7:e44571. [4]La Marca A,Sighinolfi G,Radi D,et al.Anti-Mullerian hormone(AMH)as a predictive marker in assisted reproductive technology(ART)[J].Hum Reprod Update,2010,16:113-130. [5]van Rooij IA,Broekmans FJ,te Velde ER,et al.Serum antiMullerian hormone levels:a novel measure of ovarian reserve[J].Hum Reprod,2002,17:3065-3071. [6]Roest J,van Heusden AM,Mous H,et al.The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years[J].Fertil Steril,1996,66:969-973. [7]Iliodromiti S,Kelsey TW,Wu O,et al.The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception:a systematic review and meta-analysis of the literature[J].Hum Reprod Update,2014,20:560-570. [8]Hazout A,Bouchard P,Seifer DB,et al.Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone,inhibin B,or estradiol[J].Fertil Steril,2004,82:1323-1329. [9]Eldar-Geva T,Ben-Chetrit A,Spitz IM,et al.Dynamic assays of inhibin B,anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome[J].Hum Reprod,2005,20:3178-3183. [10]Nelson SM,Yates RW,Fleming R.Serum anti-Mullerian hormone and FSH:prediction of live birth and extremes of response in stimulated cycles:implications for individualization of therapy[J].Hum Reprod,2007,22:2414-2421. [11]Nardo LG,Gelbaya TA,Wilkinson H,et al.Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization[J].Fertil Steril,2009,92:1586-1593. [12]Penarrubia J,Fabregues F,Manau D,et al.Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment[J].Hum Reprod,2005,20:915-922.
Fund_Code
厦门市科技惠民项目3502Z20144036
FileName
ZYYA201611043

Back to List